Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research

1.5. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Porters five forces analysis

3.3. Market dynamics

3.3.1. Drivers

3.3.1.1. Rise in incidence of orthopedic diseases & injury
3.3.1.2. Growth in aging population
3.3.1.3. Increase in sports injuries

3.3.2. Restraints

3.3.2.1. High cost of orthobiologics product
3.3.2.2. Stringent approval process

3.3.3. Opportunity

3.3.3.1. Improvement in healthcare infrastructure

3.4. Top player positioning, 2017

Chapter: 4: ORTHOBIOLOGICS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Demineralized bone matrix (DBM)

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Allograft

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Bone morphogenetic protein (BPM)

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Viscosupplementation products

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Synthetic bone substitutes

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Others

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

Chapter: 5: ORTHOBIOLOGICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Osteoarthritis & degenerative arthritis

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Spinal fusion

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Fracture recovery

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Soft tissue injuries

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Maxillofacial & dental applications

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

Chapter: 6: ORTHOBIOLOGICS MARKET, BY TYPE

6.1. Overview

6.1.1. Market size and forecast

6.2. Knee

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Ankle

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Hip

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Wrist & shoulder

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

6.6. Spine

6.6.1. Market size and forecast
6.6.2. Market analysis, by country

6.7. Others

6.7.1. Market size and forecast
6.7.2. Market analysis, by country

Chapter: 7: ORTHOBIOLOGICS MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Hospitals & ambulatory centers

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Research & academic institute

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Dental clinics

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

Chapter: 8: GLOBAL ORTHOBIOLOGICS MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends and opportunities

8.2.1.1. US

8.2.1.1.1. Market size and forecast, by product type
8.2.1.1.2. Market size and forecast, by application
8.2.1.1.3. Market size and forecast, by type
8.2.1.1.4. Market size and forecast, by end user

8.2.1.2. Canada

8.2.1.2.1. Market size and forecast, by product type
8.2.1.2.2. Market size and forecast, by application
8.2.1.2.3. Market size and forecast, by type
8.2.1.2.4. Market size and forecast, by end user

8.2.1.3. Mexico

8.2.1.3.1. Market size and forecast, by product type
8.2.1.3.2. Market size and forecast, by application
8.2.1.3.3. Market size and forecast, by type
8.2.1.3.4. Market size and forecast, by end user

8.2.2. North America Orthobiologics Market size and forecast, by product type
8.2.3. North America Orthobiologics Market size and forecast, by application
8.2.4. North America Orthobiologics Market size and forecast, by type
8.2.5. North America Orthobiologics Market size and forecast, by end user
8.2.6. North America Orthobiologics Market size and forecast, by region

8.3. Europe

8.3.1. Key market trends and opportunities

8.3.1.1. Germany

8.3.1.1.1. Market size and forecast, by product type
8.3.1.1.2. Market size and forecast, by application
8.3.1.1.3. Market size and forecast, by type
8.3.1.1.4. Market size and forecast, by end user

8.3.1.2. France

8.3.1.2.1. Market size and forecast, by product type
8.3.1.2.2. Market size and forecast, by application
8.3.1.2.3. Market size and forecast, by type
8.3.1.2.4. Market size and forecast, by end user

8.3.1.3. UK

8.3.1.3.1. Market size and forecast, by product type
8.3.1.3.2. Market size and forecast, by application
8.3.1.3.3. Market size and forecast, by type
8.3.1.3.4. Market size and forecast, by end user

8.3.1.4. Italy

8.3.1.4.1. Market size and forecast, by product type
8.3.1.4.2. Market size and forecast, by application
8.3.1.4.3. Market size and forecast, by type
8.3.1.4.4. Market size and forecast, by end user

8.3.1.5. Spain

8.3.1.5.1. Market size and forecast, by product type
8.3.1.5.2. Market size and forecast, by application
8.3.1.5.3. Market size and forecast, by type
8.3.1.5.4. Market size and forecast, by end user

8.3.1.6. Rest of Europe

8.3.1.6.1. Market size and forecast, by product type
8.3.1.6.2. Market size and forecast, by application
8.3.1.6.3. Market size and forecast, by type
8.3.1.6.4. Market size and forecast, by end user

8.3.2. Europe Orthobiologics Market size and forecast, by product type
8.3.3. Europe Orthobiologics Market size and forecast, by application
8.3.4. Europe Orthobiologics Market size and forecast, by type
8.3.5. Europe Orthobiologics Market size and forecast, by end user
8.3.6. Europe Orthobiologics Market size and forecast, by region

8.4. Asia-Pacific

8.4.1. Key market trends and opportunities

8.4.1.1. Japan

8.4.1.1.1. Market size and forecast, by product type
8.4.1.1.2. Market size and forecast, by application
8.4.1.1.3. Market size and forecast, by type
8.4.1.1.4. Market size and forecast, by end user

8.4.1.2. China

8.4.1.2.1. Market size and forecast, by product type
8.4.1.2.2. Market size and forecast, by application
8.4.1.2.3. Market size and forecast, by type
8.4.1.2.4. Market size and forecast, by end user

8.4.1.3. Australia

8.4.1.3.1. Market size and forecast, by product type
8.4.1.3.2. Market size and forecast, by application
8.4.1.3.3. Market size and forecast, by type
8.4.1.3.4. Market size and forecast, by end user

8.4.1.4. India

8.4.1.4.1. Market size and forecast, by product type
8.4.1.4.2. Market size and forecast, by application
8.4.1.4.3. Market size and forecast, by type
8.4.1.4.4. Market size and forecast, by end user

8.4.1.5. South Korea

8.4.1.5.1. Market size and forecast, by product type
8.4.1.5.2. Market size and forecast, by application
8.4.1.5.3. Market size and forecast, by type
8.4.1.5.4. Market size and forecast, by end user

8.4.1.6. Rest of Asia-Pacific

8.4.1.6.1. Market size and forecast, by product type
8.4.1.6.2. Market size and forecast, by application
8.4.1.6.3. Market size and forecast, by type
8.4.1.6.4. Market size and forecast, by end user

8.4.2. Asia-Pacific Orthobiologics Market size and forecast, by product type
8.4.3. Asia-Pacific Orthobiologics Market size and forecast, by application
8.4.4. Asia-Pacific Orthobiologics Market size and forecast, by type
8.4.5. Asia-Pacific Orthobiologics Market size and forecast, by end user
8.4.6. Asia-Pacific Orthobiologics Market size and forecast, by region

8.5. LAMEA

8.5.1. Key market trends and opportunities

8.5.1.1. Brazil

8.5.1.1.1. Market size and forecast, by product type
8.5.1.1.2. Market size and forecast, by application
8.5.1.1.3. Market size and forecast, by type
8.5.1.1.4. Market size and forecast, by end user

8.5.1.2. Saudi Arabia

8.5.1.2.1. Market size and forecast, by product type
8.5.1.2.2. Market size and forecast, by application
8.5.1.2.3. Market size and forecast, by type
8.5.1.2.4. Market size and forecast, by end user

8.5.1.3. South Africa

8.5.1.3.1. Market size and forecast, by product type
8.5.1.3.2. Market size and forecast, by application
8.5.1.3.3. Market size and forecast, by type
8.5.1.3.4. Market size and forecast, by end user

8.5.1.4. Rest of LAMEA

8.5.1.4.1. Market size and forecast, by product type
8.5.1.4.2. Market size and forecast, by application
8.5.1.4.3. Market size and forecast, by type
8.5.1.4.4. Market size and forecast, by end user

8.5.2. LAMEA Orthobiologics Market size and forecast, by product type
8.5.3. LAMEA Orthobiologics Market size and forecast, by application
8.5.4. LAMEA Orthobiologics Market size and forecast, by type
8.5.5. LAMEA Orthobiologics Market size and forecast, by end user
8.5.6. LAMEA Orthobiologics Market size and forecast, by region

Chapter: 9: COMPANY PROFILES

9.1. ARTHREX, INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio

9.2. EXACTECH, INC.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments

9.3. GLOBUS MEDICAL INC.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance

9.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION (DERMA SCIENCES INC.)

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance

9.5. JOHNSON & JOHNSON (DEPUY SYNTHES)

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments

9.6. MEDLINE INDUSTRIES, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating product segments
9.6.4. Product Portfolio

9.7. NUVASIVE INC.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments

9.8. STRYKER CORPORATION

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. WRIGHT MEDICAL GROUP, INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments

9.10. ZIMMER BIOMET HOLDINGS, INC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments